美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

百濟神州

346.51

+4.711.38%

盤後：345.56-0.9500-0.27%19:30 EDT

成交量：30.78萬

成交額：1.07億

市值：395.02億

市盈率：61.99

高：349.08

開：345.11

低：341.22

收：341.80

52周最高：385.22

52周最低：253.95

股本：1.14億

流通股本：8,095.27萬

量比：0.64

換手率：0.38%

股息：- -

股息率：- -

每股收益(TTM):5.59

每股收益(LYR):2.47

淨資產收益率：14.66%

總資產收益率：7.46%

市淨率：7.63

市盈率(LYR):140.29

資料載入中...

總覽公司新聞公告

【機構調研記錄】浦銀安盛基金調研英科再生、百濟神州

多家藥企高管生變：恒瑞、復星、阿斯利康、輝瑞…

一季度淨利按月暴增399%，百濟神州績後衝高7%！港股通創新藥ETF（520880）交投活躍，億元級資金提前加碼

智通港股早知道 | 碳酸鋰現貨價格大幅上行百濟神州(06160)一季度淨利潤按年增長178.02倍

異動解讀 | 一季度業績扭虧為盈並上調全年預期，百濟神州盤中大漲5.19%

核心產品放量！百濟神州一季度營收達105億元

21世纪经济报道

百悦澤海外強勢放量百濟神州上調2026年營收預期

百濟神州：2026年第一季度全球總收入15億美元按年增長35%

南方财经网

百濟神州Q1淨利潤16.08億元，按年扭虧為盈

老虎资讯综合

百濟神州首次全年盈利背後：累計虧損超600億元，大單品依賴與地緣政治隱憂

百濟神州首次全年盈利背後：累計虧損超600億元，大單品依賴與地緣政治隱憂｜財報異動透視鏡

华夏时报网

百濟神州牽手華輝安健 2000萬美元「預定」三抗獨家選擇權

每日经济新闻

財報前瞻｜百濟神州本季度營收預計增19.61%，機構觀點偏向謹慎樂觀

盈利不足兩月，百濟神州豪擲20億美元押注三抗

21世纪经济报道

潛在交易額超20億美元，百濟神州牽手華輝安健；印度太陽製藥117.5億美元收購歐加隆 | 醫藥早參

每日经济新闻

百濟神州(06160)與華輝安健簽訂《合作協議》引進三特異性創新藥全球獨家開發權益

全球化治理重構：扭虧百濟神州能否更上層樓

百濟神州：公司嚴格執行《企業會計準則》和各項具體會計準則、企業會計準則應用指南、企業會計準則解釋及其他相關規定

百濟神州首次實現全年盈利，明星產品貢獻超七成營收，近五年研發投入超630億元

红星资本局

百濟神州(ONC)小幅拉升至1.39% 陽性胃食管腺癌治療創新藥獲上市受理

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ONC/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百濟神州","latestPrice":346.51,"timestamp":1789156800000,"preClose":341.8,"halted":0,"volume":307784,"hourTrading":{"tag":"盘后","latestPrice":345.56,"preClose":346.51,"latestTime":"19:30 EDT","volume":8302,"amount":2876593.64,"timestamp":1789169408050,"change":-0.95,"changeRate":-0.002742,"amplitude":0.002742},"delay":0,"changeRate":0.013779988297249794,"floatShares":80952700,"shares":113999999,"eps":5.589356,"marketStatus":"休市中","change":4.71,"latestTime":"09-11 16:00:00 EDT","open":345.11,"high":349.08,"low":341.22,"amount":106578058.49200001,"amplitude":0.022996,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.589356,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":341.8,"preHourTrading":{"tag":"盘前","latestPrice":341.415,"preClose":341.8,"latestTime":"07:00 EDT","volume":29,"amount":9868.11652,"timestamp":1789124405727,"change":-0.385,"changeRate":-0.001126,"amplitude":0.047008},"postHourTrading":{"tag":"盘后","latestPrice":345.56,"preClose":346.51,"latestTime":"19:30 EDT","volume":8302,"amount":2876593.64,"timestamp":1789169408050,"change":-0.95,"changeRate":-0.002742,"amplitude":0.002742},"volumeRatio":0.6413230195076222,"impliedVol":0.3375,"impliedVolPercentile":0.0598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":80952700,"roa":"7.46%","roe":"14.66%","lyrEps":2.469999,"volumeRatio":0.6413230195076222,"shares":113999999,"dividePrice":0,"high":349.08,"amplitude":0.022996,"preClose":341.8,"low":341.22,"week52Low":253.9475,"pbRate":"7.63","psRate":"6.45","week52High":385.22,"institutionHeld":0,"latestPrice":346.51,"eps":5.589356,"divideRate":0,"volume":307784,"delay":0,"ttmEps":5.589356,"open":345.11,"prevYearClose":303.81,"prevWeekClose":358.26,"prevMonthClose":359.58,"prevQuarterClose":284.97,"fiveDayClose":362.68,"twentyDayClose":356.01,"sixtyDayClose":263.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"ONC","fiscalQuarterEnding":"2026/06","expectedEps":1.4,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":2.05},{"market":"US","date":"2026-05-06","symbol":"ONC","fiscalQuarterEnding":"2026/03","expectedEps":0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":1.96},{"market":"US","date":"2026-02-26","symbol":"ONC","fiscalQuarterEnding":"2025/12","expectedEps":1.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2025-11-06","symbol":"ONC","fiscalQuarterEnding":"2025/09","expectedEps":0.72,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":1.09},{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"盤前","dateTimestamp":1756526400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2963,"buy":0.7037,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7037,"analysts":27,"updateTime":1783915200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2026-09-11","current":61.99462,"percent":0.659686,"low":-217.585346,"twenty":-72.278458,"median":-24.808073,"eighty":109.442662,"high":609.337035,"avg":44.525241,"sd":209.314976,"marketCap":38863301558},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-29","current":-184.552827,"twenty":-72.8475,"median":-40.343171,"eighty":-23.581122,"marketCap":32784148770},{"date":"2025-09-05","current":-197.417514,"twenty":-73.864189,"median":-40.425269,"eighty":-23.723244,"marketCap":35069444682},{"date":"2025-09-12","current":-208.147892,"twenty":-74.224679,"median":-40.801852,"eighty":-23.82061,"marketCap":36975599617},{"date":"2025-09-19","current":-212.503459,"twenty":-75.66857,"median":-40.932054,"eighty":-23.865007,"marketCap":37749326897},{"date":"2025-09-26","current":-203.715512,"twenty":-76.587723,"median":-41.008162,"eighty":-23.928977,"marketCap":36188227257},{"date":"2025-10-03","current":-213.916471,"twenty":-77.910534,"median":-41.112345,"eighty":-23.950329,"marketCap":38000335866},{"date":"2025-10-10","current":-208.109485,"twenty":-81.639564,"median":-41.598105,"eighty":-24.044918,"marketCap":36968777077},{"date":"2025-10-17","current":-197.090466,"twenty":-85.2662,"median":-41.668284,"eighty":-24.084563,"marketCap":35011347487},{"date":"2025-10-24","current":-192.138725,"twenty":-87.584871,"median":-41.753651,"eighty":-24.09529,"marketCap":34131715179},{"date":"2025-10-31","current":-191.016991,"twenty":-89.061223,"median":-41.811067,"eighty":-24.120226,"marketCap":33932449287},{"date":"2025-11-07","current":-207.03708,"twenty":-89.680521,"median":-41.96845,"eighty":-24.175905,"marketCap":36778273935},{"date":"2025-11-14","current":594.631071,"twenty":-89.43801,"median":-41.811067,"eighty":-24.044918,"marketCap":40761959883},{"date":"2025-11-21","current":563.847015,"twenty":-89.201535,"median":-41.753651,"eighty":-23.82061,"marketCap":38651712910},{"date":"2025-11-28","current":549.835185,"twenty":-89.104768,"median":-41.685343,"eighty":-23.530029,"marketCap":37691201965},{"date":"2025-12-05","current":534.967794,"twenty":-89.063642,"median":-41.61723,"eighty":-23.184163,"marketCap":36672042310},{"date":"2025-12-12","current":517.921144,"twenty":-88.590694,"median":-41.129457,"eighty":-23.039198,"marketCap":35503494432},{"date":"2025-12-19","current":495.611986,"twenty":-88.19516,"median":-41.047814,"eighty":-22.787779,"marketCap":33974201659},{"date":"2025-12-26","current":503.21518,"twenty":-87.945005,"median":-40.950457,"eighty":-22.473183,"marketCap":34495400571},{"date":"2026-01-02","current":490.430192,"twenty":-87.636143,"median":-40.899758,"eighty":-22.105685,"marketCap":33618989662},{"date":"2026-01-09","current":517.162439,"twenty":-87.22937,"median":-40.570085,"eighty":-21.930759,"marketCap":35451485198},{"date":"2026-01-16","current":546.090088,"twenty":-85.828543,"median":-40.382553,"eighty":-21.503627,"marketCap":37434475537},{"date":"2026-01-23","current":546.929506,"twenty":-85.639801,"median":-40.307741,"eighty":-21.22036,"marketCap":37492017667},{"date":"2026-01-30","current":564.993144,"twenty":-85.550958,"median":-40.153659,"eighty":-20.966373,"marketCap":38730280050},{"date":"2026-02-06","current":560.150346,"twenty":-85.195011,"median":-40.102874,"eighty":-20.825389,"marketCap":38398306221},{"date":"2026-02-13","current":559.214072,"twenty":-84.275105,"median":-39.916618,"eighty":-20.627155,"marketCap":38334124614},{"date":"2026-02-20","current":572.225057,"twenty":-83.309792,"median":-39.846883,"eighty":-20.486836,"marketCap":39226027634},{"date":"2026-02-27","current":124.64483,"twenty":-82.630374,"median":-39.542215,"eighty":-20.122622,"marketCap":35764714896},{"date":"2026-03-06","current":113.265677,"twenty":-81.639564,"median":-39.274234,"eighty":-19.815709,"marketCap":32499660582},{"date":"2026-03-13","current":110.254986,"twenty":-80.905934,"median":-38.936161,"eighty":-19.52935,"marketCap":31635793773},{"date":"2026-03-20","current":109.257937,"twenty":-80.698984,"median":-38.812817,"eighty":-19.378455,"marketCap":31349707731},{"date":"2026-03-27","current":107.028105,"twenty":-78.593786,"median":-38.554628,"eighty":106.63856,"marketCap":30709895147},{"date":"2026-04-02","current":119.197503,"twenty":-77.951,"median":-38.396659,"eighty":109.305857,"marketCap":34201697271},{"date":"2026-04-10","current":121.122038,"twenty":-77.761122,"median":-38.192039,"eighty":109.972102,"marketCap":34753909865},{"date":"2026-04-17","current":123.949552,"twenty":-77.38927,"median":-37.882149,"eighty":113.865362,"marketCap":35565216938},{"date":"2026-04-24","current":115.875632,"twenty":-77.050014,"median":-37.033118,"eighty":115.720164,"marketCap":33248542844},{"date":"2026-05-01","current":114.357667,"twenty":-76.68,"median":-35.397875,"eighty":115.720164,"marketCap":32812988374},{"date":"2026-05-08","current":68.695502,"twenty":-76.462018,"median":-34.468285,"eighty":115.560959,"marketCap":35242166242},{"date":"2026-05-15","current":66.012693,"twenty":-76.246744,"median":-33.418249,"eighty":115.518333,"marketCap":33865831800},{"date":"2026-05-22","current":67.096218,"twenty":-76.102676,"median":-31.546239,"eighty":115.492019,"marketCap":34421701930},{"date":"2026-05-29","current":62.970154,"twenty":-75.880486,"median":-30.693232,"eighty":115.373164,"marketCap":32304948475},{"date":"2026-06-05","current":60.662245,"twenty":-75.223997,"median":-29.59006,"eighty":115.163248,"marketCap":31120945098},{"date":"2026-06-12","current":56.401824,"twenty":-74.640704,"median":-29.253094,"eighty":114.989528,"marketCap":28935263747},{"date":"2026-06-18","current":56.924083,"twenty":-74.490547,"median":-29.223519,"eighty":114.833736,"marketCap":29203193149},{"date":"2026-06-26","current":59.667569,"twenty":-74.312777,"median":-29.026044,"eighty":114.683445,"marketCap":30610656318},{"date":"2026-07-02","current":63.004827,"twenty":-74.195313,"median":-28.914242,"eighty":114.357667,"marketCap":32322736319},{"date":"2026-07-10","current":65.624791,"twenty":-74.135535,"median":-28.781271,"eighty":113.811576,"marketCap":33666830293},{"date":"2026-07-17","current":68.786518,"twenty":-74.11053,"median":-28.668245,"eighty":113.265677,"marketCap":35288859332},{"date":"2026-07-24","current":70.81271,"twenty":-74.11053,"median":-28.275697,"eighty":112.626442,"marketCap":36328336476},{"date":"2026-07-31","current":69.796363,"twenty":-73.864189,"median":-27.361812,"eighty":112.074132,"marketCap":35806930294},{"date":"2026-08-07","current":57.188468,"twenty":-73.321375,"median":-26.690447,"eighty":111.218799,"marketCap":37498879034},{"date":"2026-08-14","current":61.733374,"twenty":-72.9906,"median":-26.519964,"eighty":110.411886,"marketCap":40479005230},{"date":"2026-08-21","current":64.013629,"twenty":-72.865597,"median":-26.24637,"eighty":109.877808,"marketCap":41974184913},{"date":"2026-08-28","current":64.591063,"twenty":-72.771126,"median":-25.664335,"eighty":109.774239,"marketCap":42352812163},{"date":"2026-09-04","current":62.889975,"twenty":-72.657077,"median":-24.959227,"eighty":109.586422,"marketCap":41237396750},{"date":"2026-09-11","current":59.26931,"twenty":-72.278458,"median":-24.808073,"eighty":109.442662,"marketCap":38863301558}],"updateTime":1789274675381},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633460101","title":"【機構調研記錄】浦銀安盛基金調研英科再生、百濟神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2633460101","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633460101?lang=zh_tw&edition=fundamental","pubTime":"2026-05-08 08:41","pubTimestamp":1778200881,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月7日披露的机构调研信息，浦银安盛基金近期对2家上市公司进行了调研，相关名单如下：1)英科再生 . 　　浦银安盛基金成立于2007年，截至目前，资产管理规模3469.23亿元，排名30/212；资产管理规模1447.33亿元，排名36/212；管理公募基金数226只，排名30/212；旗下公募基金经理39人，排名33/212。旗下最近一年表现最佳的公募基金产品为浦银安盛科技创新优选混合，最新单位净值为2.64，近一年增长134.53%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/08/20260508826695.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/08/20260508826695.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260508/32208789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688235","06160","BK0239","BK1583","LU0307460666.USD","BK4526","LU1770034418.SGD","LU1719994722.HKD","BK4588","LU0588546209.SGD","688087","BK1588","LU1251922891.USD","BK1161","ONC","LU2328871848.SGD","BK0255","BK4139","LU1303224171.USD","BK1500","LU1969619763.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家藥企高管生變：恒瑞、復星、阿斯利康、輝瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633794147?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600196","BK4007","BK4592","BK4550","LU0321505868.SGD","LU1829250122.USD","LU0122379950.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU1023059063.AUD","LU2462157665.USD","SG9999003800.SGD","LU0109394709.USD","LU0225284248.USD","LU1057294990.SGD","02196","BK4581","BK4534","02142","BK4568","IE00BLSP4452.SGD","LU0985481810.HKD","LU2237443465.HKD","LU2237443978.SGD","IE00B3T34201.USD","LU2456880835.USD","SG9999002232.USD","BK4588","LU1066053197.SGD","LU1883839398.USD","SG9999011175.SGD","LU0306807586.USD","SG9999001176.SGD","LU0889565916.HKD","LU0320765992.SGD","LU2237443549.SGD","IE000M9KFDE8.USD","LU0170899867.USD","AZNH","LU0058720904.USD","LU2237443382.USD","BK4585","SGXZ57979304.SGD","ONC","LU0289739699.SGD","600276","BK4599","LU0306806265.USD","LU0321505439.SGD","LU1894683348.USD","688235","AZN","LU0868494617.USD","LU2417539215.USD","BK4533","LU0234572021.USD","LU0225771236.USD","LU2237443895.HKD","IE00B19Z3B42.SGD","LU0456855351.SGD","PFE","LU1894683264.USD","IE00BBT3K403.USD","LU2237443622.USD","IE00B19Z3581.USD","01276","IE0002270589.USD","LU2236285917.USD","SG9999001176.USD","LU1066051498.USD","SG9999013999.USD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633160523","title":"一季度淨利按月暴增399%，百濟神州績後衝高7%！港股通創新藥ETF（520880）交投活躍，億元級資金提前加碼","url":"https://stock-news.laohu8.com/highlight/detail?id=2633160523","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633160523?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 10:22","pubTimestamp":1778120520,"startTime":"0","endTime":"0","summary":"5月7日早盘，港股医药回暖。创新药龙头集体拉涨，100%创新药研发标的——港股通创新药ETF华宝一度涨1%。互联网医疗、CXO携手发力，医疗核心资产——港股通医疗ETF华宝盘中涨逾2%。　　截至发稿，港股通创新药ETF华宝回落至水面，场内持续溢价交易，显示买盘资金活跃，值得关注的是，昨日520880单日获9839万元大额净申购！　　成份股方面，权重龙头百济神州绩后跳空高开，一度冲击7%，现涨4.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-05-07/doc-inhwzrtk7838609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","LU0307460666.USD","688235","LU0588546209.SGD","LU2328871848.SGD","BK4139","BK1500","BK4585","LU1969619763.USD","BK1588","BK0239","BK4588","ONC","LU1770034418.SGD","BK1161","BK4526","06160","LU1303224171.USD","520880","LU1719994722.HKD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633166139","title":"智通港股早知道 | 碳酸鋰現貨價格大幅上行 百濟神州(06160)一季度淨利潤按年增長178.02倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2633166139","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633166139?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 07:09","pubTimestamp":1778108970,"startTime":"0","endTime":"0","summary":"前十款智能手机合计贡献了全球 25% 的出货量，创下历年第一季度最高集中度。百济神州：一季度净利润同比增长178.02倍至2.27亿美元智通财经APP讯，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","06160","VXUS","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159265378","title":"異動解讀 | 一季度業績扭虧為盈並上調全年預期，百濟神州盤中大漲5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159265378","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159265378?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 23:17","pubTimestamp":1778080652,"startTime":"0","endTime":"0","summary":"百济神州今日盘中大涨5.19%，引起了市场的广泛关注。业绩增长主要得益于核心产品百悦泽全球销售额的强劲增长，该产品第一季度销售额达75.98亿元，同比增长33.5%，其中欧洲市场增速尤为亮眼，达51.4%。与此同时，公司基于核心产品在美国市场的领先地位及在欧洲等重要市场的持续扩张，上调了2026年全年业绩指引，预计全年营业收入区间上限从450亿元提升至452亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139629","title":"核心產品放量！百濟神州一季度營收達105億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139629","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139629?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 21:26","pubTimestamp":1778073960,"startTime":"0","endTime":"0","summary":"5月6日，百济神州（纳斯达克代码：ONC；香港联交所代码：06160；上交所代码：688235.SH）发布2026年第一季度业绩报告。报告期内，公司营业总收入为105.44亿元，同比增长31.0%。产品收入占总营收98%，达103.21亿元，同比增长29.3%，主要得益于百悦泽?（泽布替尼），以及安进公司授权产品和百泽安?（替雷利珠单抗）的销售增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728968110.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728968110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633182738","title":"百悦澤海外強勢放量 百濟神州上調2026年營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2633182738","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633182738?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 18:51","pubTimestamp":1778064660,"startTime":"0","endTime":"0","summary":"5月6日，百济神州（688235/06160/BGNE）发布公告，宣布对2026年度经营业绩预测进行调整。根据最新预测，公司的营业收入将介于436亿元至452亿元之间，较之前预测的436亿元至450亿元略有上调。毛利率保持在80%区间的高位。公司的研发费用和销售及管理费用合计保持不变，仍将介于333亿元至348亿元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728793630.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728793630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181100","title":"百濟神州：2026年第一季度全球總收入15億美元 按年增長35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181100","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633181100?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 18:37","pubTimestamp":1778063820,"startTime":"0","endTime":"0","summary":"南财智讯5月6日电，百济神州（06160.HK）发布内幕消息公告，公司截至2026年3月31日止三个月未经审核简要合并财务业绩显示，全球总收入达15亿美元，同比增长35%；其中产品收入净额为14.87亿美元，同比增长34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728783666.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728783666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","LU0588546209.SGD","LU1770034418.SGD","BK4588","LU1303224171.USD","LU1719994722.HKD","LU0307460666.USD","BK0239","BK4526","BK4139","BK1588","BK1161","BK1583","ONC","BK4585","LU2328871848.SGD","BK1500","LU1251922891.USD","06160","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117917036","title":"百濟神州Q1淨利潤16.08億元，按年扭虧為盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1117917036","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117917036?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 18:34","pubTimestamp":1778063668,"startTime":"0","endTime":"0","summary":"5月6日，$百济神州(ONC)$盘前涨近5%！该公司一季度营收为105.44亿元，同比增长31%；净利润为16.08亿元，上年同期亏损9450.3万元，同比扭亏为盈。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百济神州Q1净利润16.08亿元，同比扭亏为盈","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK0239","688235","LU1719994722.HKD","BK1588","LU2328871848.SGD","LU1770034418.SGD","LU1251922891.USD","ONC","BK4526","LU1303224171.USD","BK4139","LU0307460666.USD","BK1500","BK1583","06160","LU0588546209.SGD","BK4585","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632673327","title":"百濟神州首次全年盈利背後：累計虧損超600億元，大單品依賴與地緣政治隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2632673327","media":"华夏时报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632673327?lang=zh_tw&edition=fundamental","pubTime":"2026-05-02 19:27","pubTimestamp":1777721220,"startTime":"0","endTime":"0","summary":"这家中国抗癌药明星企业交出了史上首份盈利年报，但高达612亿元的累计未弥补亏损、对单一产品的深度依赖，以及愈演愈烈的中美药品定价博弈，令其“全球肿瘤创新公司”的故事蒙上阴影。对百济神州而言，2025年本应是举杯相庆的一年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605023727569867.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605023727569867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1969619763.USD","BK0239","BK1588","BK4588","LU1770034418.SGD","LU1303224171.USD","06160","LU1719994722.HKD","LU2328871848.SGD","LU0588546209.SGD","BK1500","BK4526","BK1583","ONC","LU0307460666.USD","BK4139","688235","LU1251922891.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618011","title":"百濟神州首次全年盈利背後：累計虧損超600億元，大單品依賴與地緣政治隱憂｜財報異動透視鏡","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618011","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632618011?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 16:32","pubTimestamp":1777624341,"startTime":"0","endTime":"0","summary":"这家中国抗癌药明星企业交出了史上首份盈利年报，但高达612亿元的累计未弥补亏损、对单一产品的深度依赖，以及愈演愈烈的中美药品定价博弈，令其“全球肿瘤创新公司”的故事蒙上阴影。对百济神州而言，2025年本应是举杯相庆的一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605013727283548.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605013727283548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631351763","title":"百濟神州牽手華輝安健 2000萬美元「預定」三抗獨家選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=2631351763","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631351763?lang=zh_tw&edition=fundamental","pubTime":"2026-04-29 21:08","pubTimestamp":1777468116,"startTime":"0","endTime":"0","summary":"4月27日，创新药龙头百济神州宣布了今年第一笔授权交易。根据公告，百济神州的全资子公司广州百济神州生物制药有限公司（以下简称百济神州广州）与华辉安健（北京）生物科技有限公司（以下简称华辉安健）签订了一份《独家选择权、许可与合作协议》（以下简称《合作协议》）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604293724963718.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604293724963718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","ONC","LU0307460666.USD","BK1588","688235","BK4585","06160","BK4526","LU2328871848.SGD","LU1303224171.USD","LU0588546209.SGD","BK0239","LU1251922891.USD","LU1969619763.USD","LU1770034418.SGD","BK4139","BK4588","BK1161","LU1719994722.HKD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109645758","title":"財報前瞻｜百濟神州本季度營收預計增19.61%，機構觀點偏向謹慎樂觀","url":"https://stock-news.laohu8.com/highlight/detail?id=1109645758","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109645758?lang=zh_tw&edition=fundamental","pubTime":"2026-04-29 09:07","pubTimestamp":1777424834,"startTime":"0","endTime":"0","summary":"百济神州将于2026年05月06日发布新一季度财报，市场关注度聚焦收入增速与利润改善的持续性，以及核心产品放量节奏与费用率控制的平衡。综合一致性预期，本季度百济神州营收预计为13.36亿美元，同比增长19.61%；调整后每股收益预计为0.87美元，同比增长221.34%；息税前利润预计为1.08亿美元，同比增长243.42%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630323200","title":"盈利不足兩月，百濟神州豪擲20億美元押注三抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2630323200","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630323200?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 11:23","pubTimestamp":1777346580,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛从“年年巨亏”到“首年盈利”，百济神州用了十五年。当这面象征盈利喜悦的旗帜刚刚升起，百济神州在此节点选择花费重金与一家biotech企业达成BD（授权交易）合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721914325.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721914325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1969619763.USD","BK0239","BK1588","BK4588","LU1770034418.SGD","LU1303224171.USD","06160","LU1719994722.HKD","LU2328871848.SGD","LU0588546209.SGD","BK1500","BK4526","BK1583","ONC","LU0307460666.USD","BK4139","688235","LU1251922891.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630634690","title":"潛在交易額超20億美元，百濟神州牽手華輝安健；印度太陽製藥117.5億美元收購歐加隆 | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2630634690","media":"每日经济新闻","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630634690?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 07:04","pubTimestamp":1777331069,"startTime":"0","endTime":"0","summary":"丨2026年4月28日星期二丨NO.1百济神州与华辉安健签订合作协议4月27日，百济神州发布公告，其全资子公司广州百济神州生物制药有限公司获得华辉安健PD-1、VEGFA及CTLA-4的三特异性化合物（包括HH160）在全球范围内的开发、生产和商业化独家许可。根据协议，百济神州支付2000万美元预付款；若在限期内行使选择权，需支付1亿美元行权费。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721014223.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721014223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","BK4588","06160","LU1303224171.USD","BK1515","BK1574","BK4585","LU2328871848.SGD","BK1191","ONC","688235","BK1500","BK1161","BK1583","BK4139","BK1588","LU1719994722.HKD","159938","LU1251922891.USD","BK4526","LU1969619763.USD","LU0588546209.SGD","LU1770034418.SGD","09939","LU0307460666.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393872","title":"百濟神州(06160)與華輝安健簽訂《合作協議》引進三特異性創新藥全球獨家開發權益","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393872","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393872?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 19:03","pubTimestamp":1777287828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2026 年 4 月 24 日，公司全资子公司百济神州广州与华辉安健签订了一份《合作协议》。此外，华辉安健同意在相关里程碑达成后，向百济神州广州支付其被百济神州广州授予相关知识产权许可的对价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","06978","BK0239","LU0588546209.SGD","BK1588","LU1969619763.USD","ONC","159992","BK4139","LU1251922891.USD","BK1583","BK4588","LU1719994722.HKD","BK1574","LU0307460666.USD","BK4585","06160","BK4526","LU1770034418.SGD","BK1161","LU1303224171.USD","BK1500","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630351799","title":"全球化治理重構：扭虧百濟神州能否更上層樓","url":"https://stock-news.laohu8.com/highlight/detail?id=2630351799","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630351799?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 12:52","pubTimestamp":1777265520,"startTime":"0","endTime":"0","summary":"从北生所的科研转化试验田起步，完成从Biotech（生物技术）到全球化Biopharma（生物制药）的蜕变，“创新药一哥”百济神州（688235.SH/06160.HK/ONC）在进阶之路上再迎关键里程碑。2025年，百济神州迎来发展关键突破，营收实现382.25亿元，同比增长40.46%；归母净利润14.61亿元，实现成立以来首次全年扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273719924335.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273719924335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","BK1583","BK1500","BK4585","LU1251922891.USD","LU1303224171.USD","LU1770034418.SGD","BK4588","BK1588","06160","BK1161","ONC","LU1969619763.USD","LU0588546209.SGD","LU2328871848.SGD","BK0239","BK4139","BK4526","LU0307460666.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628093746","title":"百濟神州：公司嚴格執行《企業會計準則》和各項具體會計準則、企業會計準則應用指南、企業會計準則解釋及其他相關規定","url":"https://stock-news.laohu8.com/highlight/detail?id=2628093746","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628093746?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 17:30","pubTimestamp":1776677400,"startTime":"0","endTime":"0","summary":"证券日报网讯4月20日，百济神州在互动平台回答投资者提问时表示，公司已在2026年4月15日披露的《百济神州2025年年度报告》中详细披露报告期内的公司营业收入、销售费用、管理费用的变动原因。公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定，财务数据客观公允反映公司财务状况和生产经营成果，不存在跨期结转成本费用的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604203710742828.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710742828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1251922891.USD","LU1719994722.HKD","BK1500","BK0239","LU0588546209.SGD","LU2328871848.SGD","LU0307460666.USD","688235","BK1161","BK1588","BK4585","BK1583","BK4139","LU1969619763.USD","LU1303224171.USD","ONC","LU1770034418.SGD","06160","BK4526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627218484","title":"百濟神州首次實現全年盈利，明星產品貢獻超七成營收，近五年研發投入超630億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627218484","media":"红星资本局","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627218484?lang=zh_tw&edition=fundamental","pubTime":"2026-04-16 20:11","pubTimestamp":1776341502,"startTime":"0","endTime":"0","summary":"红星资本局4月16日消息，成立16年的A股创新药龙头百济神州（688235.SH；6160.HK），在2025年度正式盈利。4月14日晚，百济神州发布2025年年报，全年实现营业收入382.25亿元，同比增长40.46%；实现归母净利润14.61亿元，实现扭亏为盈，2024年同期公司亏损49.78亿元。红星资本局注意到，百济神州的盈利，主要靠抗肿瘤类药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604163707695829.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604163707695829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","688235","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627423635","title":"百濟神州(ONC)小幅拉升至1.39% 陽性胃食管腺癌治療創新藥獲上市受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2627423635","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627423635?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 23:34","pubTimestamp":1776267252,"startTime":"0","endTime":"0","summary":"金吾财讯 |百济神州(ONC)盘中小幅拉升，截至发稿，报314.69美元，上涨1.39%，成交额1512.97万美元。消息面上，百济神州周一宣布，旗下百赫安®(泽尼达妥单抗)与百泽安®(替雷利珠单抗)针对HER2阳性胃食管腺癌一线治疗的新增适应症上市许可申请，获国家药监局药品审评中心正式受理。有业内分析人士称，该药的上市或有望打破该领域十余年未有实质性突破的治疗僵局。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299268","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU1251922891.USD","LU1719994722.HKD","BK1500","BK0239","IPOS","LU0588546209.SGD","LU2328871848.SGD","LU0307460666.USD","159992","688235","BK1161","BK1588","BK4585","BK1583","BK4139","06978","LU1969619763.USD","LU1303224171.USD","ONC","LU1770034418.SGD","06160","BK4526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":169,"code":"91000000","status":"200"}]}}